A Study to Learn if 3 Doses of the 20vPnC Vaccine Were Safe in Healthy Infants and if 20vPnC Produced Antibody Responses Against a Germ Called Streptococcus pneumoniae
A Study to Learn if 3 Doses of the 20vPnC Vaccine Were Safe in Healthy Infants and if 20vPnC Produced
Antibody Responses Against a Germ Called Streptococcus pneumoniae. A Phase 3, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine Given as a Series of 2 Infant Doses and 1 Toddler Dose in Healthy Infants.
Category & Conditions: Vaccine-related Conditions
Medicine: PF-06482077
ClinicalTrials.gov Identifier (NCT): NCT04546425
Protocol ID: B7471012
PrintDownloadOpen Plain Language Summary Result: Click here